Insider buying
~$269K25K sh @ $10.76
Traded Dec 3, 2024 · filed 2 days later
The CEO of Zenas Biopharma paid $269K out of pocket for Zenas Biopharma shares. Shares held went up 15% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
3 tracked managers disclosed the same change for Q3 2024. Among this manager's largest new positions for Q3 2024.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
New
Compared with the manager's Q2 2024 13F
1,562,942
0.44%
Within the filing's reported positions, not the manager's total assets
3
For Q3 2024
Insider buying
Traded Dec 3, 2024 · filed 2 days later
The CEO of Zenas Biopharma paid $269K out of pocket for Zenas Biopharma shares. Shares held went up 15% with this purchase.
Insider buying
Traded Dec 4, 2024 · filed 1 day later
The CEO of Zenas Biopharma paid $449K out of pocket for Zenas Biopharma shares. Shares held went up 23% with this purchase.
Insider buying
Traded Nov 18, 2024 · filed 2 days later
The CEO of Zenas Biopharma paid $113K out of pocket for Zenas Biopharma shares. It was the first purchase in over a year.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.